Literature DB >> 16634362

Atherogenesis in rheumatology.

S I van Leuven1, J J P Kastelein, D P D'Cruz, G R Hughes, E S Stroes.   

Abstract

Atherosclerosis is a chronic inflammatory disorder characterized by immune cell activation, inflammation driven plaque formation and subsequent destabilization. In other disorders of an inflammatory nature, the chronic inflammatory state per se has been linked to acceleration of the atherosclerotic process which is underlined by an increased incidence of cardiovascular disease (CVD) in disorders such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and antiphopholipid (Hughes) syndrome (APS). In addition to systemic inflammation, additional mechanisms have been put forward that are more specific for the pathophysiology of the individual chronic inflammatory disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16634362     DOI: 10.1191/0961203306lu2273rr

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  9 in total

1.  Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus.

Authors:  Hiromi Kizu; Hiroaki Dobashi; Tomohiro Kameda; Kentaro Susaki; Masahiko Kawanishi; Toshihiko Ishida
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

2.  Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness.

Authors:  T A Gheita; H A Raafat; S Sayed; H El-Fishawy; M M Nasrallah; E Abdel-Rasheed
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

Review 3.  Statin therapy in lupus-mediated atherogenesis: two birds with one stone?

Authors:  Sander I van Leuven; Yanice V Mendez-Fernandez; Erik S Stroes; Paul P Tak; Amy S Major
Journal:  Ann Rheum Dis       Date:  2010-11-10       Impact factor: 19.103

4.  Dehydroepiandrosterone in systemic lupus erythematosus.

Authors:  Amr H Sawalha; Susan Kovats
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

5.  Myocardial ischemia in Wegener's granulomatosis: coronary atherosclerosis versus vasculitis.

Authors:  Giuseppe Cocco; Armen Yuri Gasparyan
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

Review 6.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

7.  Inflammation and atherosclerosis: disease modulating therapies.

Authors:  Mahesh J Patel; Michael A Blazing
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-12

8.  Systemic Sarcoidosis Presenting with Renal Involvement Caused by Various Sarcoidosis-associated Pathophysiological Conditions.

Authors:  Sayo Ueda; Taichi Murakami; Hirokazu Ogino; Motokazu Matsuura; Masanori Tamaki; Seiji Kishi; Mike Hann; Yuko Toyoda; Kojiro Nagai; Yoshimi Bando; Hideharu Abe; Yasuhiko Nishioka; Toshio Doi
Journal:  Intern Med       Date:  2018-11-19       Impact factor: 1.271

9.  Discovery and implementation of transcriptional biomarkers of synthetic LXR agonists in peripheral blood cells.

Authors:  Elizabeth A DiBlasio-Smith; Maya Arai; Elaine M Quinet; Mark J Evans; Tad Kornaga; Michael D Basso; Liang Chen; Irene Feingold; Anita R Halpern; Qiang-Yuan Liu; Ponnal Nambi; Dawn Savio; Shuguang Wang; William M Mounts; Jennifer A Isler; Anna M Slager; Michael E Burczynski; Andrew J Dorner; Edward R LaVallie
Journal:  J Transl Med       Date:  2008-10-16       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.